Full Year 2021 financial results: Pascal Soriot, CEO

Full Year 2021 financial results: Pascal Soriot, CEO

Full Year 2021 AstraZeneca financial resultsПодробнее

Full Year 2021 AstraZeneca financial results

Full Year 2020 financial results: Pascal SoriotПодробнее

Full Year 2020 financial results: Pascal Soriot

CEO Pascal Soriot reflects on AstraZeneca's H1 2019 ResultsПодробнее

CEO Pascal Soriot reflects on AstraZeneca's H1 2019 Results

AstraZeneca CEO Pascal Soriot breaks down data on new 'transformative' breast cancer drugПодробнее

AstraZeneca CEO Pascal Soriot breaks down data on new 'transformative' breast cancer drug

Pascal Soriot, CEO, AstraZenecaПодробнее

Pascal Soriot, CEO, AstraZeneca

Q3 2021 AstraZeneca financial resultsПодробнее

Q3 2021 AstraZeneca financial results

Leaders with Lacqua: Astrazeneca CEO Pascal SoriotПодробнее

Leaders with Lacqua: Astrazeneca CEO Pascal Soriot

H1 2021 financial results: Pascal Soriot, CEOПодробнее

H1 2021 financial results: Pascal Soriot, CEO

H1 2021: AstraZeneca financial resultsПодробнее

H1 2021: AstraZeneca financial results

Pascal Soriot thanks our people for their commitment and passionПодробнее

Pascal Soriot thanks our people for their commitment and passion

Full Year 2020: AstraZeneca financial resultsПодробнее

Full Year 2020: AstraZeneca financial results

CEO Pascal Soriot on COVID-19 vaccine - CNNПодробнее

CEO Pascal Soriot on COVID-19 vaccine - CNN

Full Year and Q4 2022 resultsПодробнее

Full Year and Q4 2022 results

LIVE: Reuters Newsmaker with AstraZeneca CEO Pascal SoriotПодробнее

LIVE: Reuters Newsmaker with AstraZeneca CEO Pascal Soriot

Q1 2021: AstraZeneca financial resultsПодробнее

Q1 2021: AstraZeneca financial results

Pascal Soriot, AstraZeneca: Real Innovation Requires RiskПодробнее

Pascal Soriot, AstraZeneca: Real Innovation Requires Risk

AstraZeneca CEO says manufacturing Covid-19 vaccine is a 'huge undertaking'Подробнее

AstraZeneca CEO says manufacturing Covid-19 vaccine is a 'huge undertaking'

Promo: Meet Pascal Soriot, AstraZeneca's 'turnaround' CEOПодробнее

Promo: Meet Pascal Soriot, AstraZeneca's 'turnaround' CEO